IMM-01

N/A

Report date: 2026/01/21 20:00:47

Base Information

Drug NameIMM-01
Drug Alias NameIMM-01
ClassificationBiologics
Mechanisms of ActionImmunostimulantsTransforming growth factor beta inhibitorsInterleukin-2 receptor agonists
TargetsTransforming growth factor betaInterleukin-2 receptor
Therapy Area/IndicationsUveal melanomaSolid tumoursColorectal Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesImmunova LLC
China Registration ClassN/A

Develop Information

Active CompaniesModulate Therapeutics LtdImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsUveal melanomaSolid tumoursColorectal Neoplasms +[6] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A